Desensitization of mu-opioid receptor-evoked potassium currents: initiation at the receptor, expression at the

Christophe Blanchet1, Christian Lüscher

  • 1Pharmacology, Department of Physiology, and Neurology, University of Geneva, CH 1211 Geneva, Switzerland.

Insights

Sustained stimulation of mu-opioid receptors (MORs) desensitizes G protein-coupled inwardly rectifying potassium (GIRK) currents. This desensitization is G protein-mediated and can be overcome by stronger signals, impacting other receptors.

Area of Science:

  • Neuroscience
  • Molecular Pharmacology
  • Cell Signaling

Background:

  • G protein-coupled receptor (GPCR) signaling is crucial for neuronal function.
  • Mu-opioid receptors (MORs) are key GPCRs involved in pain and reward pathways.
  • Desensitization is a common mechanism limiting GPCR response duration.

Purpose of the Study:

  • To investigate the desensitization mechanisms of G protein-coupled inwardly rectifying potassium (GIRK) currents activated by MORs.
  • To determine if MOR desensitization is initiated at the receptor and expressed at the effector level.
  • To explore the role of G protein signaling intensity in GIRK current reactivation and heterologous effects.

Main Methods:

  • Electrophysiological recordings in locus coeruleus neurons.
  • Stimulation of mu-opioid receptors (MORs) with varying intensities.
  • Analysis of G protein-coupled inwardly rectifying potassium (GIRK) current kinetics and desensitization.
  • Investigation of cross-talk between different GPCRs converging on GIRK channels.

Main Results:

  • MOR stimulation intensity dictates the degree of GIRK current desensitization.
  • Postsynaptic GIRK current desensitization occurs rapidly, while presynaptic effects remain stable.
  • Desensitized GIRK currents can be reactivated by increased G protein signaling intensity.
  • MOR desensitization exhibits heterologous effects on other GPCR-mediated responses via GIRK channels.

Conclusions:

  • MOR desensitization is a G protein-dependent process initiated at the receptor.
  • A slowly developing pathway mediates MOR-induced GIRK current desensitization, leading to competitive inhibition of channel activation.
  • MORs exert bidirectional control over GIRK channels, influencing both direct and heterologous signaling pathways.

Related Concept Videos

Opioid Receptors: Overview01:22

Opioid Receptors: Overview

Opioid receptors, including the mu (μ, MOR), delta (δ, DOR), and kappa (κ, KOR) types, belong to the rhodopsin family of G protein-coupled receptors. These receptors are located throughout the central and peripheral nervous systems and in non-neuronal tissues such as macrophages and astrocytes. Opioid receptor ligands can be categorized into agonists or antagonists. Highly selective agonists include [d-Ala2, MePhe4, Gly(ol)5]-enkephalin or DAMGO for MOR, [D-Pen2, D-Pen5]-enkephalin or DPDPE for...
GPCR Desensitization01:12

GPCR Desensitization

G protein-coupled receptor (GPCR) signaling plays a crucial role in cell functioning. GPCR desensitization is an equally essential process. It allows cells to respond to changing environments and regain sensitivity to new stimuli while preventing unnecessary stimulation when no longer needed. Prolonged exposure to stimuli leads to GPCR desensitization. It involves blocking the receptors from binding and activating additional G proteins. This inhibits activation of downstream effectors, thereby...
Analgesia and Pain Management01:25

Analgesia and Pain Management

Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
Desensitization and Tachyphylaxis01:20

Desensitization and Tachyphylaxis

Tachyphylaxis is described as a rapid decrease in response to a drug after repeated or continuous administration of the same drug dose. It is a phenomenon where the body becomes less responsive to a particular substance or intervention over time, requiring higher doses or stronger interventions to achieve the same effect. It results from adaptive changes in the body's receptors, signaling pathways, or physiological processes that occur in response to prolonged exposure to a stimulus.
Several...
Ligand-Gated Ion Channel Receptor: Gating Mechanism01:30

Ligand-Gated Ion Channel Receptor: Gating Mechanism

Ligand-gated ion channels are transmembrane proteins that play a vital role in intercellular communication and functions of the nervous system. They allow the influx of ions across the membrane once the neurotransmitter binds, allowing the subsequent transmission of electrical excitation across the neurons. Other ligand-gated ion channels, like the γ-aminobutyric acid (GABA) receptor, permit anions like chloride into the cells on the binding of the GABA molecule. Their entry into the cell...
Mechanically-gated Ion Channels01:12

Mechanically-gated Ion Channels

Mechanically-gated ion channels are proteins found in eukaryotic and prokaryotic cell membranes that open in response to mechanical stress. Tension, compression, swelling, and shear stress can alter the conformation of the protein, opening a transmembrane channel that allows the passage of ions for signal transmission. In eukaryotes, mechanically-gated channels are distributed in several regions like the neurons, lungs, skin, bladder, and heart, where they play critical roles in numerous...